Hologic, Inc. logo

HOLX

Hologic, Inc.

$71.53

Earnings Summary

Revenue
$1002.7Mn
Net Profits
$228.4Mn
Net Profit Margins
22.78%
PE Ratio
12.39

Highlights

Revenue:

Hologic, Inc.’s revenue fell -14.17% since last year same period to $1002.7Mn in the Q2 2022. On a quarterly growth basis, Hologic, Inc. has generated -30.16% fall in its revenue since last 3-months.

Net Profits:

Hologic, Inc.’s net profit fell -14.9% since last year same period to $228.4Mn in the Q2 2022. On a quarterly growth basis, Hologic, Inc. has generated -49.88% fall in its net profits since last 3-months.

Net Profit Margins:

Hologic, Inc.’s net profit margin fell -0.85% since last year same period to 22.78% in the Q2 2022. On a quarterly growth basis, Hologic, Inc. has generated -28.24% fall in its net profit margins since last 3-months.

PE Ratio:

Hologic, Inc.’s price-to-earnings ratio after this Q2 2022 earnings stands at 12.39.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Hologic, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.63
EPS Estimate Current Year
0.63

Highlights

EPS Estimate Current Quarter:

Hologic, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.63 - a -11.27% fall from last quarter’s estimates.

EPS Estimate Current Year:

Hologic, Inc.’s earning per share (EPS) estimates for the current year stand at 0.63.

Key Ratios

Key ratios of the Hologic, Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
0.95
Return on Assets (ROA)
0.13
Return on Equity (ROE)
0.34
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Hologic, Inc.’s earning per share (EPS) fell -28.57% since last year same period to 0.95 in the Q2 2022. This indicates that the Hologic, Inc. has generated -28.57% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Hologic, Inc.’s return on assets (ROA) stands at 0.13.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Hologic, Inc.’s return on equity (ROE) stands at 0.34.

Dividend Per Share (DPS):

Hologic, Inc. declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-27
0.71
0.95
33.8%
2022-04-27
1.6
2.07
29.37%

Company Information

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

Organisation
Hologic, Inc.
Headquarters
Marlborough, Massachusetts, US
Employees
5.81K
Industry
Health Technology
CEO
Stephen MacMillan